Educational information, not medical advice — ask your doctor or midwife.
Track Kigen-to with reminders and record whether it helped, in the app.
Kigen-to is a five-herb Japanese Kampo formula equivalent to the classical Chinese formula Gui Zhi Tang, one of the oldest and most foundational prescriptions in East Asian medicine. It combines cinnamon twig, white peony root, licorice root, ginger, and jujube date into a balanced formula designed to gently open the body's defenses and restore equilibrium. It has been standardized in Japan and is available as a pharmaceutical-grade granule preparation prescribed by licensed physicians.
The formula works by supporting the body's natural immune and circulatory response at the surface level — helping ease muscle tension, mild fever, and sweating associated with early illness. Cinnamon twig warms circulation and promotes a gentle sweat to clear pathogens; white peony root softens and relaxes muscles and blood vessels; licorice and jujube harmonize the formula and support energy; and ginger warms the digestive system to aid absorption and reduce nausea.
In Japan, Kigen-to is most commonly dispensed as TJ-45 granules (Tsumura brand), a standardized pharmaceutical preparation. Traditional practitioners may also prepare it as a raw herb decoction boiled in water. Granules are dissolved in hot water and consumed as a tea-like drink, which is the most clinically studied and standardized form.
Gui Zhi Tang (the Chinese equivalent of Kigen-to) first appeared in the Shang Han Lun (Treatise on Cold Damage Disorders), written by Zhang Zhongjing around 200 CE — one of the most influential medical texts in East Asian history. When Chinese medicine traveled to Japan and evolved into Kampo, this formula remained a cornerstone prescription. It is referenced in more classical case studies and commentaries than nearly any other formula in the tradition, valued for its elegant simplicity and wide applicability.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Kigen-to is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.